I've been fortunate enough to work at two so far. At Aperio I was on the team that designed a digital pathology instrument. At the time this was pretty new tec

I've been fortunate enough to work at two so far. At Aperio I was on the team that designed a digital pathology instrument. At the time this was pretty new tech. We were purchased by Leica a little more than four years ago. After that I went to epic sciences. We will be releasing our first LDT this year in a partnership with Genomic Health. It's a blood based prostate cancer test with demonstrated clinical utility, the first of its kind in the CTC space as far as I'm aware.